Literature DB >> 22963760

Survival and functional restoration of human fetal ventral mesencephalon following transplantation in a rat model of Parkinson's disease.

Anika Rath1, Alexander Klein, Anna Papazoglou, Jan Pruszak, Joanna Garcia, Martin Krause, Jaroslaw Maciaczyk, Stephen B Dunnett, Guido Nikkhah.   

Abstract

Cell replacement therapy by intracerebral transplantation of fetal dopaminergic neurons has become a promising therapeutic option for patients suffering from Parkinson's disease during the last decades. However, limited availability of human fetal tissue as well as ethical issues, lack of alternative nonfetal donor cells, and the absence of standardized transplantation protocols have prevented neurorestorative therapies from becoming a routine procedure in patients suffering from neurodegenerative diseases. Improvement of graft survival, surgery techniques, and identification of the optimal target area are imperative for further optimization of this novel treatment. In the present study, human primary fetal ventral mesencephalon-derived tissue from 7- to 9-week-old human fetuses was transplanted into 6-hydroxydopamine-lesioned adult Sprague-Dawley rats. Graft survival, fiber outgrowth, and drug-induced rotational behavior up to 14 weeks posttransplantation were compared between different intrastriatal transplantation techniques (full single cell suspension vs. partial tissue pieces suspension injected by glass capillary or metal cannula) and the intranigral glass capillary injection of a full (single cell) suspension. The results demonstrate a higher survival rate of dopamine neurons, a greater reduction in amphetamine-induced rotations (overcompensation), and more extensive fiber outgrowth for the intrastriatally transplanted partial (tissue pieces) suspension compared to all other groups. Apomorphine-induced rotational bias was significantly reduced in all groups including the intranigral group. The data confirm that human ventral mesencephalon-derived cells serve as a viable cell source, survive in a xenografting paradigm, and functionally integrate into the host tissue. In contrast to rat donor cells, keeping the original (fetal) neuronal network by preparing only a partial suspension containing tissue pieces seems to be beneficial for human cells, although a metal cannula that causes greater tissue trauma to the host is required for injection. In addition, homotopic intranigral grafts may represent a complimentary grafting approach to the "classical" ectopic intrastriatal target site in PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963760     DOI: 10.3727/096368912X654984

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  16 in total

Review 1.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

2.  Biodistribution of Glial Progenitors in a Three Dimensional-Printed Model of the Piglet Cerebral Ventricular System.

Authors:  Rohit K Srivastava; Anna Jablonska; Chengyan Chu; Lydia Gregg; Jeff W M Bulte; Raymond C Koehler; Piotr Walczak; Miroslaw Janowski
Journal:  Stem Cells Dev       Date:  2019-03-28       Impact factor: 3.272

3.  Induced pluripotent stem cells in rat models of Parkinson's disease: A systematic review and meta-analysis.

Authors:  Yunxia Zhang; Meiling Ge; Qiukui Hao; Birong Dong
Journal:  Biomed Rep       Date:  2018-01-30

Review 4.  Cell-based therapies for Parkinson disease—past insights and future potential.

Authors:  Roger A Barker; Janelle Drouin-Ouellet; Malin Parmar
Journal:  Nat Rev Neurol       Date:  2015-08-04       Impact factor: 42.937

5.  Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease.

Authors:  Shane Grealish; Elsa Diguet; Agnete Kirkeby; Bengt Mattsson; Andreas Heuer; Yann Bramoulle; Nadja Van Camp; Anselme L Perrier; Philippe Hantraye; Anders Björklund; Malin Parmar
Journal:  Cell Stem Cell       Date:  2014-11-06       Impact factor: 24.633

6.  DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor.

Authors:  Patrick Aldrin-Kirk; Andreas Heuer; Gang Wang; Bengt Mattsson; Martin Lundblad; Malin Parmar; Tomas Björklund
Journal:  Neuron       Date:  2016-05-05       Impact factor: 17.173

7.  Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.

Authors:  Su-Ping Peng; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

Review 8.  Historical perspective of cell transplantation in Parkinson's disease.

Authors:  Alejandra Boronat-García; Magdalena Guerra-Crespo; René Drucker-Colín
Journal:  World J Transplant       Date:  2017-06-24

9.  Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson's Disease.

Authors:  Stefanie Seiler; Stefano Di Santo; Lukas Andereggen; Hans R Widmer
Journal:  Front Cell Neurosci       Date:  2017-05-26       Impact factor: 5.505

10.  Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Alejandra Boronat-García; Marcela Palomero-Rivero; Magdalena Guerra-Crespo; Diana Millán-Aldaco; René Drucker-Colín
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.